Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy

Status:
Recruiting

Trial end date:
2022-05-31

Target enrollment:

Participant gender:

The purpose of this study is to look at the effect that the study drug OPC has on AGE levels in patients with prostate cancer.

Phase 2

Medical University of South Carolina

Androgens
Metformin